China is the firm's main export market.
Zhong said Oceania wanted to attract investment from China and Chinese investors considered listed firms more trustworthy and transparent.
"It's very hard for them to get information from the private company," he said.
Zhong said Oceania would raise capital through issuing new shares at some point, although no timeline had been set.
"If we need it, we will raise capital."
He said the opportunity in China for Oceania was huge, with the natural health products market in that country worth $100 billion.
Oceania expects total revenue of $3.4 million in the year to March 31 this year, rising to $5.4 million in the following financial year, according to the firm's key operating milestones included in its listing document.